Highlights and Quick Summary
- EBT margin for the quarter ending June 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin decreased by NaN%
- Annual EBT margin for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual EBT margin for 2020 was 0.0% (a NaN% decrease from previous year)
- Annual EBT margin for 2019 was 0.0% (a NaN% decrease from previous year)
- Twelve month EBT margin ending June 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing EBT margin decreased by NaN% year-over-year
Trailing EBT margin for the last four month:
30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
---|---|---|---|
0.0% | 0.0% | 0.0% | 0.0% |
Visit stockrow.com/PHAT
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Phathom Pharmaceuticals, Inc.
Most recent EBT marginof PHAT including historical data for past 10 years.Interactive Chart of EBT margin of Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. EBT margin for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | 0.0% | 0.0% | – | – | – |
2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2020 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2019 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
2018 | 0.0% | – | – | – | 0.0% |
Business Profile of Phathom Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology